Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India

BACKGROUND: There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and conseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Kristen M., Pai, Madhukar, Dowdy, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412573/
https://www.ncbi.nlm.nih.gov/pubmed/25918999
http://dx.doi.org/10.1371/journal.pone.0124525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412573/
https://www.ncbi.nlm.nih.gov/pubmed/25918999
http://dx.doi.org/10.1371/journal.pone.0124525

Ejemplares similares